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Abstract
Pregnancy and breastfeeding make demands on maternal nutrient stores. The extent of
depletion and the degree to which nutrient stores are replenished between pregnancies
has implications for a mother's nutritional status at conception of the subsequent child
and therefore that child's birth outcomes and growth. Using follow-up data collected
several years after a randomized effectiveness trial conducted in rural Bangladesh and
a randomized efficacy trial conducted in semiurban Ghana, we evaluated the impact of
maternal supplementation with small-quantity lipid-based nutrient supplements (LNS)
or multiple micronutrients (MMN) through pregnancy (the index pregnancy) and
6 months postpartum on the growth status of the next living younger sibling conceived
and born after the index pregnancy. In both Bangladesh (n = 472 younger siblings) and
Ghana (n = 327 younger siblings), there were no overall differences in the growth sta-
tus or the prevalence of undernutrition among younger siblings whose mothers had
received LNS (or MMN, Ghana only) during and after the index pregnancy compared
with the younger siblings of mothers who had received iron plus folic acid (IFA) during
the index pregnancy (Ghana) or during and for 3 months after the index pregnancy
(Bangladesh). These findings do not indicate that preconception nutrition interventions
do not improve child growth. Rather, they suggest that any benefits of maternal LNS or
MMN supplementation during one pregnancy and for 6 months postpartum are
unlikely to extend to the growth of her next child beyond any effects due to IFA alone.
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1 | INTRODUCTION
The first 1,000 days, spanning the period from conception through
24 months of age, is often referred to as the “critical window of
opportunity” for improving maternal and child nutrition (de Onis &
Branca, 2016; Victora et al., 2010). Poor maternal and child nutrition
during this period increases morbidity and mortality and can have
adverse long-term effects on health, cognitive development, human
capital acquisition, and economic productivity in adulthood (Black
et al., 2013; World Bank, 2006). For this reason, many nutrition inter-
ventions focus on improving maternal nutrition during pregnancy
and/or child nutrition during the first 2 years. More recently, the pre-
conception period has received increasing attention as another criti-
cal, and generally overlooked, window for improving maternal
nutrition and child outcomes (Barker et al., 2018; De-Regil, Harding, &
Roche, 2016; Stephenson et al., 2018).
The preconception period, which is any interval of time in which a
woman of reproductive age (15–49 years) is not pregnant, includes
the period before first pregnancy and any interpregnancy intervals
(De-Regil et al., 2016). Several studies have shown a significant associ-
ation between preconception maternal nutritional status and birth
outcomes (Ramakrishnan et al., 2012; Young et al., 2015) or precon-
ception maternal nutrition and child growth (Young et al., 2018). How-
ever, the global nutrition community has focused mainly on the first
1,000 days as the critical window of opportunity for improving birth
outcomes and child growth, and the potential role of maternal nutri-
tion during the preconception period has only recently gained atten-
tion (Bhutta, 2019). Thus, there is limited evidence on the impact of
maternal nutrition interventions during the preconception period,
including the importance of the specific timing and duration of the
preconception intervention, on birth outcomes and child growth. A
few studies have evaluated the effect of preconception nutrition
interventions on birth outcomes (Hambidge et al., 2019; Nguyen
et al., 2017; Potdar et al., 2014; Ramakrishnan et al., 2016). In the
most recent trial, conducted in four low- and middle-income coun-
tries, maternal supplementation with a lipid-based nutrient supple-
ment (LNS) starting at least 3 months before conception improved
foetal growth, but the impact on foetal growth did not significantly
differ from the impact observed when the supplement was started
late in the first trimester (Hambidge et al., 2019). Whether preconcep-
tion nutrition has an effect on growth measured later in childhood
remains relatively unknown. One study in Vietnam showed improved
linear growth at 2 years of age among children whose mothers had
received preconception multiple micronutrients (MMN) or iron and
folic acid compared with those who had received preconception folic
acid (Nguyen et al., 2017), but more evidence is needed.
In this study, we contribute new evidence on the impact of
maternal nutrient supplementation prior to conception on child
growth status. Although most preconception maternal nutrition inter-
vention trials have provided mothers with supplementation during the
preconception period immediately before conception and through
delivery, we explored the relationship from a different time point dur-
ing the maternal preconception period. Specifically, we assessed the
impact of maternal supplementation during pregnancy (the index
pregnancy) and the first 6 months postpartum on the growth status of
her next living child conceived after the index pregnancy. Our ana-
lyses were based on follow-up data that were collected several years
after two randomized controlled trials: the Rang-Din Nutrition Study
(RDNS) effectiveness trial in Bangladesh and the International Lipid-
based Nutrient Supplements-DYAD-G efficacy trial in Ghana. These
trials were designed to assess the impact of combined maternal and
child supplementation throughout much of the first 1,000 days on
child birth and growth outcomes (Adu-Afarwuah et al., 2016; Adu-
Afarwuah et al., 2015; Dewey et al., 2017; Mridha et al., 2016). During
pregnancy and for 6 months postpartum, women who participated in
the trials were provided with daily small-quantity (20 g/day; 118 kcal/
day) LNS (both trials) or MMN capsules (DYAD-G trial only), whereas
other women received daily iron-folic acid (IFA) capsules during preg-
nancy and for 3 months postpartum (RDNS trial) or during pregnancy
only (DYAD-G trial). The infants born to women during the trials,
referred to here as index children, also participated in the trials, with
children in some arms receiving supplements from 6 to 18 or
24 months of age (described in detail in the methods section).
The effects of these interventions on index child and maternal
outcomes varied across the two trials. In Bangladesh, maternal supple-
mentation with LNS during pregnancy improved several birth out-
comes, including a reduction in the prevalence of newborn stunting
(Mridha et al., 2016), and comprehensive LNS supplementation
(maternal supplementation during pregnancy and the first 6 months
postpartum plus child supplementation from 6 to 24 months of age)
Key messages
• Although maternal supplementation with small-quantity
lipid-based nutrient supplements or multiple micro-
nutrients during pregnancy and for 6 months postpartum
is likely to improve maternal nutrition prior to the next
pregnancy, we did not find a significant impact on the
growth status of the subsequent child, compared with
maternal supplementation with iron plus folic acid.
• Maternal supplementation with small-quantity lipid-
based nutrient supplements ormultiple micronutrients
during pregnancy and for six months postpartum is likely
toimprove maternal nutrition prior to the next pregnancy.
• We did not find a significant impact on the growth status
of the subsequent child,compared to maternal supple-
mentation with iron plus folic acid.
• In these studies, the average gap between the end of
maternal supplementation andconception of the next
child was 15 months in Bangladesh and 25 months
inGhana; in such scenarios, improvements in maternal
nutrition may not be sustainedthrough conception of the
subsequent child.
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improved child growth and development through 24 months of age
(Dewey et al., 2017; Matias et al., 2017). In the mothers, those in the
LNS group experienced less household food insecurity (Adams et al.,
2017) and improved anthropometric indices during pregnancy among
those >25 years (Matias et al., 2016), but no differences in vitamin A
status during pregnancy (Dewey et al., 2016) or in anaemia, iron sta-
tus, or iodine status at 6 months postpartum (Matias et al., 2018;
Mridha et al., 2017). In Ghana, maternal supplementation with LNS
during pregnancy increased birth size, particularly among infants of
first-time mothers (Adu-Afarwuah et al., 2015), and mean attained
length at 18 months of age was higher among children in the compre-
hensive maternal and child LNS supplementation group (Adu-
Afarwuah et al., 2016). In the mothers, those in the LNS group were
less likely to experience inadequate weight gain during pregnancy
(Adu-Afarwuah et al., 2017a) and had improved essential fatty-acid
status during pregnancy and postpartum (Oaks et al., 2017), and those
who received LNS or MMN had improved vitamin B12 (Shahab-Fer-
dows et al., 2019) and iodine status (Adu-Afarwuah et al., 2018) but
did not differ in anaemia, iron status, or breast milk vitamin A concen-
tration at 6 months postpartum or in household food insecurity, com-
pared with those who received IFA (Adams et al., 2017; Adu-
Afarwuah et al., 2017b; Klevor et al., 2016).
As part of the follow-up to the randomized trials, we collected
anthropometric data on the next child born after the index pregnancy
and evaluated the impact of maternal supplementation with LNS or
with MMN, compared with maternal supplementation with IFA, on
the growth status of these younger siblings. We hypothesized that
maternal supplementation with LNS, or with MMN, during pregnancy
and the first 6 months postpartum, compared with maternal supple-
mentation with IFA during pregnancy only or during pregnancy and
the first 3 months postpartum, may have led to improved maternal
nutritional status at the conception of the subsequent child, thereby
improving the younger siblings' growth status.
2 | METHODS
2.1 | Randomized trials
The RDNS trial was implemented by University of California, Davis, in
partnership with the International Center for Diarrheal Diseases
Research, Bangladesh, LAMB, and the Food and Nutrition Technical
Assistance III Project of Family Health International 360. RDNS was a
cluster-randomized effectiveness trial conducted in 11 rural unions of
the Badarganj and Chirirbandar subdistricts in the northwest region of
Bangladesh. LAMB, one of the implementing partners, was a non-
governmental organization that provided community-based health
services to women and children in the study area. LAMB community
health workers delivered the supplements to women and children
who participated in the trial, and study clusters were defined based
on the LAMB community health workers' 64 work areas.
Pregnant women who were 20 weeks of gestation or less were
enrolled into the RDNS trial on a rolling basis between October 2011
and August 2012. Enrolled women (n = 4,011) were assigned to one
TABLE 1 Rang-Din Nutrition Study and DYAD-G intervention groups as defined during the main trials and for follow-up sibling analyses
RDNS intervention groups
Main trial Follow-up younger sibling analysisa
(1) Comprehensive LNS: Women received 20 g of LNS per day through pregnancy and the first 6 months
postpartum, and their children received 20 g of LNS per day from 6–24 months of age.
(1) LNS (Comprehensive LNS)
(2) Child-only LNS: Women received daily IFA capsules during pregnancy and the first 3 months postpartum,
and their children received 20 g LNS from 6–24 months.
(2) IFA (Child-only LNS + Child-only
MNP + Control)
(3) Child-only MNP: Women received daily IFA capsules during pregnancy and the first three months
postpartum, and their children received micronutrient powder from 6–24 months.
(4) Control: Women received daily IFA capsules during pregnancy and the first 3 months postpartum
(no child supplementation).
DYAD-G intervention groups
Main trial Follow-up younger sibling analysisb
(1) LNS: Women received 20 g/day LNS during pregnancy and the first 6 months postpartum followed by
20 g/day LNS for the infant from 6 to 18 months of age.
(1) LNS
(2) MMN: Women received daily multiple micronutrient capsules during pregnancy and the first 6 months
postpartum and no infant supplementation.
(2) MMN
(3) IFA: Women received daily iron–folic acid capsules during pregnancy, a low-dose calcium placebo capsule
for the first 6 months postpartum and no infant supplementation.
(3) IFA
Abbreviations: IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN, multiple micronutrient; MNP, micronutrient powder.
aThe current analysis was conducted using follow-up data collected several years after the “main trial,” a randomized effectiveness trial in Bangladesh.
Intervention groups for the follow-up analysis were as defined in the “follow-up younger sibling analysis” column.
bThe current analysis was conducted using follow-up data collected several years after the “main trial,” a randomized efficacy trial in Ghana. Intervention
groups for the follow-up analysis were as defined in the “follow-up younger sibling analysis” column.
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of four intervention groups (defined in Table 1) based on their resi-
dence within one of the 64 clusters, with 16 randomly assigned clus-
ters per arm. The original RDNS minimum sample size calculation of
778 women per group (total of 3,152 women) was based on detecting
an effect size of 0.2 for comparison of continuous outcomes between
any two groups with a one-sided hypothesis test at the 5% level of
significance with 80% power and assuming an intracluster correlation
of 0.01 (Mridha et al., 2016).
The DYAD-G trial was implemented by the Lipid-based Nutrient
Supplements Project between December 2009 and March 2014 in
the semiurban Yilo Krobo and Lower Manya Krobo districts of the
Eastern Region of Ghana. Between December 2009 and December
2011, pregnant women who were 20 weeks of gestation or less and
at least 18 years of age were enrolled on a rolling basis. Women were
randomly assigned to one of three intervention groups (Table 1).
The DYAD-G sample size calculations were based on detecting an
effect size of 0.3 for comparison of continuous outcomes between
any two groups with a two-sided hypothesis test at the 5% level of
significance and with 80% power (Adu-Afarwuah et al., 2015).
Because of a temporary mislabelling of the IFA and MMN supple-
ments (described later), additional women were enrolled to allow for
sufficient power to assess pregnancy outcomes if women who
temporarily received a mislabelled supplement were excluded. In total,
1,320 women were enrolled and randomized (n = 440 for the LNS
group, n = 439 for the MMN group, and n = 441 for IFA group;
Adu-Afarwuah et al., 2015).
The nutrient composition of each of the maternal supplements is
provided in Table S1 in the online supporting material (OSM). Both
main trials received ethical approval and were registered at
clinicaltrials.gov.
2.2 | Follow-up data collection
Several years after the completion of each of the main trials, we car-
ried out follow-up studies to collect additional data from the mothers
who had participated in the trials, the index children, and other mem-
bers of the index children's families. The RDNS follow-up occurred
from January to August 2016, when the index children were ~40–
52 months of age, whereas the follow-up to the DYAD-G trial
occurred between January and December of 2016 when the index
children were 4–6 years of age. All of the women who participated in
the main trials as well as the index children born during the main trials
were eligible to participate in the follow-up study.
As a component of the follow-up data collection activities in both
countries, we collected anthropometric data on the closest younger
living sibling born after the index child. All closest younger siblings
born after the index children were eligible for follow-up anthropomet-
ric measurements with several exceptions. We did not attempt to col-
lect sibling anthropometric data in cases where the woman who
participated in the main trial or the index child had died, nor did we
attempt follow-up data collection when the woman had a misdi-
agnosed pregnancy, miscarriage, or stillbirth during the main trial. In
cases of younger sibling twins, both twins were measured, and one
twin was randomly selected for inclusion in the younger sibling
analyses.
For eligible younger siblings who participated in the follow-up
study, anthropometric measurements were taken at a central location
or in participants' homes. A team of anthropometrists trained to
World Health Organization (WHO) standards performed all sibling
anthropometric measurements according to WHO standard proce-
dures (de Onis et al., 2004). The recumbent length of siblings under
24 months of age (or under 85 cm in DYAD-G) was measured to the
nearest 0.1 cm using an infantometer, whereas standing height of
those 24 months of age and older was measured to the nearest
0.1 cm using a stadiometer. For all younger siblings, weight was mea-
sured to the nearest 50 g using an electronic scale (Seca 874), and a
Shorr tape was used to measure mid-upper arm circumference and
head circumference to the nearest 0.1 cm.
In Ghana, anthropometric data were entered into tablets that
were preprogrammed using Open Data Kit software. The Open Data
Kit data entry forms included preprogrammed quality checks to
ensure data were entered for all relevant questions/measurements
and to prevent entry of implausible values. All measurements were
performed twice and, once entered into the form, were automatically
compared for agreement. If the difference between the first two mea-
surements exceeded a predefined threshold (>0.5 cm for length/
height, mid-upper arm circumference, and head circumference;
>0.1 kg for weight), the anthropometrists received a software-gener-
ated prompt to take and enter a third measurement. In Bangladesh,
anthropometric data were collected on paper forms. The difference in
the first two anthropometric measurements was manually calculated,
and a third measurement was taken if the difference between the first
two measurements exceeded the same predefined thresholds as were
used in Ghana.
The University of California, Davis and the Center for Diarrheal
Diseases Research, Bangladesh provided ethical approval for the
RDNS follow-up study as a modification to the main study protocol.
The DYAD-G follow-up study received approval from the ethics com-
mittees of the University of California, Davis, the Ghana Health Ser-
vice, and the University of Ghana College of Basic and Applied
Sciences. Prior to participation in both follow-up studies, mothers
(or caregivers) provided written informed consent.
2.3 | Younger sibling subsample and statistical
analysis
Our analyses assessed the impact of maternal LNS or MMN supple-
mentation during the index pregnancy and for the first 6 months post-
partum on the growth of the next living child conceived after the
index pregnancy. To evaluate this impact, we generated younger sib-
ling anthropometric outcomes on the basis of the WHO 2006 Growth
Standards (WHO, 2006). These outcomes were length-for-age
z score/height-for age z score, weight-for-age z score, weight-for-
length z score/weight-for-height z score, body mass index (BMI)-for
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age z score, head circumference-for-age z score (HCZ), and mid-upper
arm circumference-for-age z score. We defined sibling stunting as
length-for-age z score/height-for age z score < −2, wasting as weight-
for-length z score/weight-for-height z score < −2, and underweight as
weight-for-age z score< −2.
We developed a statistical analysis plan prior to conducting the
analyses. All analyses were performed using SAS version 9.4 (SAS Inst.
Cary, NC, USA). Hypothesis tests were two-sided at the 5% level of
significance. On the basis of the full samples of women initially ran-
domized into the main trials, we began by assessing the overall and
group-specific rates of attrition at follow-up. We tested for by-group
differences in attrition and summarized and compared the background
characteristics between the follow-up and lost to follow-up samples.
We also assessed by-group differences in the proportion of index chil-
dren who had a younger sibling in the follow-up sample.
We assessed balance in three ways. First, we summarized and
compared the baseline characteristics of the follow-up and lost to fol-
low-up samples, which were defined based on the initial randomiza-
tions. Next, among the full follow-up sample, we summarized and
tested for differences in background characteristics between those
with and without a younger sibling. Finally, among the follow-up sam-
ple with a younger sibling, we summarized background characteristics
and tested for differences in these characteristics by intervention
group. Background characteristics included a household asset index
score and the household food insecurity access scale score. Principal
components analysis was used to construct the asset index based on
household ownership of a set of assets, housing characteristics, and
water and sanitation sources, where a higher score indicated a rela-
tively better socioeconomic status (Vyas & Kumaranayake, 2006). The
household food insecurity access scale score, which ranged from 0 to
27 with a higher score indicating more severe food insecurity, was
based on self-reported answers about the frequency of experiencing
each of nine food insecurity access conditions (Coates, Swindale, &
Bilinsky, 2007).
The primary analyses were by intention-to-treat, that is, by-group
analyses were according to group assignment regardless of any proto-
col violations. We also performed a secondary per-protocol analysis
on the basis of self-reported maternal adherence to her assigned sup-
plement during the main trial. In particular, the per-protocol samples
were limited to the next youngest children of women with at least
60% reported adherence during pregnancy and the period of postpar-
tum supplementation.
For RDNS, the by-group primary and per-protocol analyses com-
pared two groups on the basis of assigned maternal supplement
(Table 1): LNS (comprehensive LNS groups) versus IFA (combined
child-only LNS, child-only micronutrient powder, and control groups).
Exploratory analyses were also conducted to test for differences
among the four child intervention arms. The DYAD-G primary and
per-protocol analyses were based on tests for differences among the
three intervention groups (LNS, MMN, and IFA). When the global null
hypothesis of no difference between the three groups was rejected at
the 5% level, we performed post hoc pairwise group comparisons
corrected for multiple hypothesis testing using the Tukey–Kramer
adjustment. We also conducted two additional sets of DYAD-G ana-
lyses. First, where no differences between the IFA and MMN groups
were found, we conducted secondary analyses to test for differences
between the LNS group and the combined IFA and MMN groups. Sec-
ond, during the main trial, a temporary mislabelling of the capsules
provided to women during pregnancy (described in Adu-Afarwuah
et al., 2015) meant that 170 women assigned to the IFA group actu-
ally received MMN capsules for part or all of their pregnancy (and IFA
for the remainder of the maternal supplementation period), whereas
170 women assigned to the MMN group actually received IFA cap-
sules for part or all of their pregnancy (then MMN for the remainder
of the maternal supplementation period). We therefore conducted an
additional “as received” analyses in which group assignments cor-
responded to the supplements women actually received at
enrollment.
The statistical models estimated to detect by-group differences in
sibling anthropometric outcomes were site-specific to account for the
differing designs of each of the main trials. For the RDNS follow-up
sibling sample, continuous outcomes were modelled using mixed-
model linear regression, whereas mixed-model logistic regressions
were used to analyse dichotomous sibling outcomes. Each of the
mixed models accounted for the regionally cluster-randomized design
of the main RDNS trial by including the effect of union (nested within
subdistrict) and the random effect of cluster (nested within interven-
tion group). With our RDNS observed sample size of 472 younger sib-
lings and assuming a two-sided hypothesis test at the 5% level of
significance with 80% power and an intracluster correlation of 0.01, in
two-group comparisons, we had sufficient power to detect a mean
difference of >0.36 SD for continuous outcomes, and using the con-
trol group stunting rate as the reference prevalence of stunting, a dif-
ference of >16% in stunting.
Randomization in the DYAD-G main trial was at the individual
level, so continuous and dichotomous outcomes for younger sib-
lings in the DYAD-G follow-up sample were modelled using ordi-
nary least squares and logistic regression, respectively. With our
DYAD-G observed sample size of roughly 300 younger siblings and
again assuming a two-sided hypothesis test at the 5% level of sig-
nificance with 80% power, we had sufficient power to detect a
mean difference of >0.36 SD in two group comparisons and a
mean difference of >0.46 SD in three-group comparisons of contin-
uous outcomes. Using the control group stunting rate as the refer-
ence prevalence of stunting, we had power to detect a difference
in stunting of >12% in two-group comparisons and >14% in three-
group comparisons.
For both RDNS and DYAD-G, all models included a fixed-effect
control for sibling age at the time of measurement. Fully adjusted ana-
lyses included sibling age at the time of measurement in addition to
other prespecified covariates, potentially including maternal age at
enrollment, maternal years of education at enrollment, maternal
height at enrollment, predicted maternal prepregnancy BMI, maternal
parity at enrollment, household asset index score, household food
insecurity access scale score, younger sibling age at growth measure-
ment, younger sibling sex, and birth interval between index child and
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younger sibling. Among the potential covariates, only those that were
at least marginally associated (p < .1) with a specific sibling anthropo-
metric outcome in bivariate analysis were included in the fully
adjusted regression model for that outcome.
3 | RESULTS
3.1 | Attrition and balance
The RDNS main trial enrolled 4,011 women. Data of any kind were
collected from 3,440 households at the 40–52-month follow-up,
resulting in an overall attrition rate of 14.2%, which did not differ
between intervention groups (14.1% in the LNS group vs. 14.3% in
the IFA group, p = .940). Excluding households that were not targeted
for follow-up because of miscarriage or stillbirth during the main trial
or because the index child had died before the end of the main trial,
the rate of successful follow-up was 98.3% (3,440/3,499).
The DYAD-G main trial enrolled 1,320 women, and follow-up
data of any kind were collected from 1,040 households at the 4–6-
year follow-up. The overall DYAD-G attrition rate at follow-up was
therefore 21.2%, which was marginally significantly different between
intervention groups (17.7% in the LNS group vs. 22.8% in the MMN
group vs. 23.1% in the IFA group, p = .092). Again excluding house-
holds that were not targeted for follow-up (due to miscarriage, still-
birth, or index-child death during the main trial), the DYAD-G rate of
successful follow-up was 85.1% (1,040/1,222).
The baseline characteristics of the follow-up and lost to follow-up
samples are summarized and compared in Table S2. In both the RDNS
(top panel) and DYAD-G (bottom panel) samples, there were statisti-
cally significant differences in the characteristics of the follow-up and
lost to follow-up samples, though in all cases, the magnitude of the
differences was small.
Of the 3,440 households in the RDNS follow-up sample,
472 (13.7%) had a younger sibling with anthropometric data. Among
households in the overall follow-up sample, 16.1% in the LNS group
had a younger sibling compared with 12.9% in the IFA group (p = .04).
In Ghana, 327 of the 1,440 households (31.4%) in the DYAD-G follow-
up sample had a younger sibling with anthropometric data, which did
not differ by group (29.8% [LNS] vs. 34.2% [MMN] vs. 30.4% [IFA], p =
.569). Table 2 summarizes and compares the background characteris-
tics of these two groups (those with a younger sibling with anthropo-
metric data and those without a younger sibling) within the follow-up
samples. In the RDNS follow-up sample, compared with those without
a younger sibling in the follow-up sample, the mothers of those with a
younger sibling were younger and more likely to be nulliparous when
they enrolled in the main trial and had a slightly lower prepregnancy
(prior to the index pregnancy) BMI and slightly lower household asset
index scores. In the DYAD-G follow-up sample, households with a
younger sibling tended to include mothers who were younger when
they enrolled in the main trial, mothers who were slightly taller, and
mothers for whom the first child was the index child.
Table 3 shows that the intervention groups were balanced in
terms of baseline characteristics and background characteristics (sex
TABLE 2 Baseline characteristics of follow-up samples with and without a younger sibling
Trial Variable
Has younger sibling No younger sibling
p valuebN M ± SD or %a N M ± SD or %a
RDNS Maternal age (y) 472 20.2 ± 3.8 2968 22.2 ± 5.0 <.001
Maternal education (y) 472 6.0 ± 3.1 2968 6.3 ± 3.3 .091
Maternal height (cm) 472 150.4 ± 5.4 2968 150.7 ± 5.4 .238
Maternal prepregnancy BMI (kg/m2) 472 19.8 ± 2.6 2968 20.0 ± 2.7 .029
Mother nulliparous at index pregnancy (%) 472 58.5 2965 36.5 <.001
Household asset index score 472 −0.2 ± 2.2 2968 0.1 ± 2.3 .008
HFIAS score (0–27) 472 3.3 ± 4.3 2968 2.9 ± 3.9 .137
DYAD-G Maternal age (y) 327 25.7 ± 4.6 713 27.3 ± 5.7 <.001
Maternal education (y) 327 7.9 ± 3.5 713 7.6 ± 3.6 .220
Maternal height (cm) 323 159.5 ± 5.6 700 158.7 ± 5.7 .050
Maternal prepregnancy BMI (kg/m2) 322 24.3 ± 4.1 700 24.7 ± 4.6 .111
Mother nulliparous at index pregnancy (%) 327 37.9 713 29.6 .008
Household asset index score 327 0.0 ± 1.0 710 0.0 ± 1.0 .678
HFIAS score (0–27) 325 2.3 ± 3.8 708 2.7 ± 4.4 .116
Note. The values of baseline characteristics are from the baseline of the main randomized trials.
Abbreviations: BMI, body mass index; HFIAS, household food insecurity access scale.
aValues are M ± SD for continuous variables and percentage for dichotomous variables.
bFor continuous variables, p values for tests of difference in mean between follow-up samples with and without a younger sibling based on mixed model
linear regressions (RDNS) or ordinary least squares regressions (DYAD-G). For dichotomous variables, p values for tests of difference in proportion
between follow-up samples with and without a younger sibling based on mixed model logistic regressions (RDNS) or logit regressions (DYAD-G).
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TABLE 4 Continuous younger sibling anthropometric outcomes
Trial Variable
LNS IFA MMN
p valuebN Mean (95% CI) N Mean (95% CI) N Mean (95% CI)
RDNS HAZ/LAZ 144 −1.44 [−1.66, −1.22] 325 −1.54 [−1.70, −1.38] .398
WAZ 145 −1.39 [−1.59, −1.19] 326 −1.40 [−1.54, −1.26] .945
WHZ/WLZ 144 −0.81 [−0.97, −0.65] 325 −0.74 [−0.84, −0.64] .494
BMIZ 144 −0.79 [−0.93, −0.65] 325 −0.66 [−0.76, −0.56] .160
HCZ 145 −1.61 [−1.77, −1.45] 326 −1.64 [−1.76, −1.52] .794
MUACZa 127 −0.53 [−0.71, −0.35] 293 −0.51 [−0.63, −0.39] .862
DYAD-G HAZ/LAZ 85 −0.87 [−1.11, −0.63] 94 −0.91 [−1.15, −0.67] 96 −0.91 [−1.15, −0.67] .964
WAZ 86 −0.57 [−0.79, −0.35] 90 −0.54 [−0.76, −0.32] 94 −0.68 [−0.90, −0.46] .626
WHZ/WLZ 85 −0.13 [−0.35, 0.09] 90 −0.04 [−0.26, 0.18] 94 −0.25 [−0.45, −0.05] .357
BMIZ 85 −0.03 [−0.25, 0.19] 90 0.07 [−0.15, 0.29] 94 −0.16 [−0.36, 0.04] .322
HCZ 98 −0.84 [−1.04, −0.64] 99 −0.55 [−0.75, −0.35] 107 −0.71 [−0.89, −0.53] .102
MUACZa 81 −0.44 [−0.62, −0.26] 86 −0.38 [−0.56, −0.20] 95 −0.58 [−0.74, −0.42] .211
Abbreviations: BMIZ, body mass index-for age z score; HAZ/LAZ, height-for-age z score/length-for-age z score; HCZ, head circumference-for-age z score;
IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN, multiple micronutrient; MUACZ, mid-upper arm circumference-for-age z score; WAZ,
weight-for-age z score; WHZ/WLZ, weight-for-height z score/weight-for-length z score.
aMUACZ calculated for children 3 months of age and older.
bAll models control for younger sibling age at growth measurement.
TABLE 3 Characteristics of follow-up sample with younger sibling by intervention group
Trial Variable
LNS IFA MMN
p valuecN M ± SD or %b N M ± SD or %b N M ± SD or %b
RDNS Maternal agea (y) 145 19.9 ± 3.4 327 20.3 ± 4.0 .301
Maternal educationa (y) 145 5.9 ± 2.5 327 6.1 ± 3.3 .777
Maternal heighta (cm) 145 150.7 ± 5.5 327 150.3 ± 5.4 .443
Maternal prepregnancy BMIa (kg/m2) 145 19.5 ± 2.5 327 19.9 ± 2.6 .185
Mother nulliparousa (%) 145 57.2 327 49.6 .718
Household asset index scorea 145 −0.4 ± 1.8 327 -0.1 ± 2.3 .159
HFIAS scorea (0–27) 145 3.2 ± 4.2 327 3.3 ± 4.4 .993
Sibling female (%) 145 52.4 327 52.0 .929
Birth interval between index child and sibling (m) 145 30.1 ± 7.9 327 29.7 ± 8.3 .644
Sibling age at measurement (m) 145 13.6 ± 8.1 326 13.8 ± 8.4 .787
DYAD-G Maternal agea (y) 108 25.7 ± 4.5 103 25.4 4.8 116 26.0 ± 4.5 .627
Maternal educationa (y) 108 8.1 ± 3.7 103 8.1 3.7 116 7.4 ± 3.2 .250
Maternal heighta (cm) 106 159.6 ± 5.2 102 159.1 6.4 115 159.7 ± 5.3 .709
Maternal prepregnancy BMIa (kg/m2) 106 24.7 ± 4.1 102 23.7 3.7 114 24.4 ± 4.4 .242
Mother nulliparousa (%) 108 42.6 103 40.8 116 31.0 .159
Household asset index scorea 108 −0.1 ± 1.0 103 0.1 1.1 116 0.0 ± 1.0 .193
HFIAS scorea (0–27) 107 2.2 ± 3.8 103 1.8 3.4 115 2.6 ± 4.0 .285
Sibling female (%) 99 38.4 99 47.5 109 43.1 .435
Birth interval between index child and sibling (m) 108 39.9 ± 12.7 103 36.5 ± 11.1 116 38.7 ± 12.0 .116
Sibling age at measurement (m) 108 22.4 ± 13.0 103 24.3 ± 12.9 116 24.6 ± 12.7 .285
Abbreviations: BMI, body mass index; HFIAS, household food insecurity access scale; IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN,
multiple micronutrient; RDNS, Rang-Din Nutrition Study.
aDenotes baseline characteristics from the original randomized trial.
bValues are M ± SD for continuous variables and percentage for dichotomous variables.
cFor continuous variables, p values for tests of difference in mean between groups based on mixed model linear regressions (RDNS) or ordinary least
squares regressions (DYAD-G). For dichotomous variables, p values for tests of difference in proportion between groups based on mixed model logistic
regressions (RDNS) or logit regressions (DYAD-G).
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and birth interval) of the younger siblings in both the RDNS and
DYAD-G follow-up samples of younger siblings with anthropometric
measurements. The average birth interval between the index child
and the younger sibling was ~30 months in the RDNS sample and
~39 months in the DYAD-G sample.
3.2 | Younger sibling growth
The effects of the intervention on continuous and dichotomous sib-
ling growth status outcomes are shown in Tables 4 and 5, respec-
tively. Among younger siblings in the RDNS follow-up sample, who
were on average 13.8 months (standard deviation of 8.3) of age at
measurement, there were no significant differences in any of the con-
tinuous growth status outcomes between siblings of mothers who
received LNS in the previous pregnancy and the first 6 months post-
partum compared with siblings of mothers who received IFA. Like-
wise, there were no differences in the prevalence of stunting, wasting,
or underweight between the two groups. Tables S3 and S4 in the
OSM show that, comparing the four RDNS child intervention arms,
there were no differences in the continuous and dichotomous out-
comes, respectively. The observed intracluster correlation for each
outcome was essentially zero.
Among younger siblings in the DYAD-G follow-up sample, who
were on average 21.2 months (standard deviation of 13.4) of age at
measurement, the continuous and dichotomous growth status out-
comes were not significantly different among the LNS, MMN, and IFA
groups. Notably, however, there was a substantial difference in the
prevalence of stunting in the LNS group compared with the IFA group
(9.4% in the LNS group vs. 20.2% in the IFA group; relative risk 0.53
[0.25, 1.46]), though the difference was not statistically significant (p =
.139). Tables S5 and S6 show the DYAD-G results comparing the LNS
group with the combined IFA and MMN groups. There were no differ-
ences between these two groups in any of the continuous or dichoto-
mous outcomes, but again, there was a notable difference that did not
reach statistical significance in stunting between groups (9.4% in the
LNS group vs. 16.8% in the combined IFA + MMN group, p = 095).
As shown in Tables S7 and S8 in the OSM, these findings did not
change for either RDNS or DYAD-G based on the fully adjusted
models that controlled for predefined baseline covariates. The results
of the per-protocol analyses are shown in Tables S9 and S10 in the
OSM. Among just the sample of siblings for whom the mother
reported consuming her assigned supplement on at least 60% of the
days during pregnancy and the postpartum period of supplementa-
tion, there were no group differences in any of the continuous or
dichotomous outcomes in either the RDNS or DYAD-G samples.
Finally, Tables S11 and S12 in the OSM show the effects on the
continuous and dichotomous, respectively, DYAD-G sibling growth
status outcomes on the basis of the “as received” analyses in which
group assignments correspond to the supplements women actually
received at enrollment in Ghana. These results showed a difference in
the mean HCZ among groups (p = .042). Pairwise group comparisons,
corrected for multiple hypothesis testing using the Tukey–Kramer
adjustment, showed the mean HCZ was significantly lower in the LNS
group compared with the MMN group (estimated difference in mean
HCZ of −0.32 [−0.63, −0.01], p = .043).
4 | DISCUSSION
Although there is increasing recognition of the potential importance
of maternal preconception nutrition for birth outcomes and child
growth, there is relatively little evidence directly evaluating the effect
of interventions that improve maternal nutrition during the precon-
ception period on these outcomes. The analyses presented here eval-
uated the potential for longer term benefits of maternal
supplementation during pregnancy and postpartum on the growth sta-
tus of the next child born after the index pregnancy/postpartum
period. In both Bangladesh and Ghana, overall we found no differ-
ences in growth status or the prevalence of undernutrition among
younger siblings whose mothers had received LNS (or MMN in Ghana)
during the index pregnancies and postpartum periods, compared with
younger siblings of mothers who had received IFA. However, in both
Bangladesh and Ghana, the prevalence of stunting was lower
TABLE 5 Dichotomous younger sibling anthropometric outcomes
Trial Variable
LNS IFA MMN
p valueaN Prevalence (95% CI) N Prevalence (95% CI) N Prevalence (95% CI)
RDNS Stunted 144 29.2 [23.9, 34.4] 325 34.2 [28.3, 40.0] .439
Wasted 144 7.6 [3.8, 11.5] 325 9.2 [6.7, 11.8] .603
Underweight 145 24.1 [18.3, 30.0] 326 28.5 [22.7, 34.3] .418
DYAD-G Stunted 85 9.4 [3.2, 15.6] 94 20.2 [12.1, 28.3] 96 13.5 [6.68, 20.4] .139
Wasted 85 1.2 [−1.1, 3.5] 90 3.3 [−0.4, 7.1] 94 2.1 [-0.79, 5.1] .600
Underweight 86 5.8 [0.9, 10.8] 90 12.2 [5.4, 19.0] 94 11.7 [5.19, 18.2] .305
Note. Stunted defined as height-for-age z score/length-for-age z score < −2. Wasted defined as weight-for-height z score/weight-for-length z score < −2.
Underweight defined as WAZ < −2.
Abbreviations: IFA, iron–folic acid; LNS, lipid-based nutrient supplements; MMN, multiple micronutrient; RDNS, Rang-Din Nutrition Study.
aAll models control for younger sibling age at growth measurement.
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(5 percentage points in Bangladesh and >10 percentage points in
Ghana) among siblings whose mothers had received LNS compared
with those who had received IFA, though we had relatively low power
to detect differences in dichotomous outcomes and these differences
in the prevalence of stunting were not statistically significant.
Other available evidence, from three trials that started precon-
ception maternal supplementation at least 3 months prior to concep-
tion, is mixed. A recent multicountry (Democratic Republic of the
Congo, Guatemala, India, and Pakistan) randomized controlled trial
showed no difference in birth outcomes in the group that received
daily LNS starting at least 3 months before conception compared with
the group that received LNS starting late in the first trimester of preg-
nancy, though birth outcomes in both LNS groups were improved rel-
ative to the control group that did not receive supplementation
(Hambidge et al., 2019). An earlier food-based intervention in India
showed no difference in birth weight among the infants of women
who were provided with a nutrient-dense daily snack prior to concep-
tion and through pregnancy, compared with the infants of women
provided a similar snack but with low micronutrient content (control;
Potdar et al., 2014). However, among women who began consuming
the snack 90 days or more before their last menstrual period, birth
weight was higher in the nutritious snack group compared with the
control group. Finally, in a study in Vietnam that provided preconcep-
tion women with either daily IFA, daily MMN, or daily folic acid sup-
plements, there were no differences in birth outcomes in either the
group that received MMN or the group that received IFA compared
with the group that received folic acid, even among the subgroup of
women who received their assigned supplement for at least 26 weeks
before conception (Ramakrishnan et al., 2016). However, a follow-up
to that study found that, at 2 years of age, the children of women
who received preconception MMN or preconception IFA had
improved linear growth and reduced risk of stunting compared with
those who received only folic acid (Nguyen et al., 2017).
Our findings of no intervention group differences in growth sta-
tus or the prevalence of undernutrition among younger siblings have
several possible explanations. The first is that the control group in
both trials received IFA, which by itself may have had a positive
impact on maternal nutritional status prior to conception of the next
child. In the trial in Vietnam (Nguyen et al., 2017), preconception
MMN and IFA were both shown to improve linear growth at 2 years
of age compared with preconception folic acid alone. In our trials,
the daily dose of iron contained in the IFA capsules was 60 mg,
whereas the daily dose of iron in the MMN capsules and the LNS
was 20 mg (Table S1). Thus, it is possible that there was no detect-
able advantage of LNS or MMN beyond the effect of the IFA.
Another possibility is that improved maternal nutritional status during
the trials was not sustained through conception with her next child.
It is possible, for example, that after 6 months postpartum and the
end of maternal supplementation, continued demands on maternal
nutrient stores during the remainder of lactation could have depleted
stores of some nutrients, such as fat-soluble vitamins. On average,
the gap between the end of maternal supplementation at 6 months
postpartum and conception of her next child was ~15 months in the
RDNS sample and ~25 months in the DYAD-G sample. Therefore,
any effect of improved maternal nutritional status at 6 months post-
partum may have been diminished by the time the younger sibling
was conceived.
This analysis had several strengths. First, the rate of successful
follow-up was high for both studies (~98% in RDNS and ~85% in
DYAD-G). Another strength was that the differences between the
study sites in Bangladesh and Ghana improved the external validity of
our results. Bangladesh and Ghana have differing background rates of
maternal and child undernutrition: In Bangladesh in 2014, 36% of chil-
dren under 5 years of age were stunted, and 31% of ever-married
women of reproductive age had low BMI (BMI < 18.5; National Insti-
tute of Population Research and Training (NIPORT), Mitra and Associ-
ates, & ICF International, 2016), whereas in Ghana in 2014, the
prevalence of stunting among children under age 5 was 19%, and
prevalence of low BMI among women of reproductive age was 6%
(Ghana Statistical Service, Ghana Health Service, & ICF International,
2015). The external validity of our results was also strengthened due
to the study samples being drawn from different populations in each
country (rural in Bangladesh and semiurban in Ghana) as well as the
differing study designs between the two countries, with the RDNS
study designed as an effectiveness trial and DYAD-G as an efficacy
trial.
The results of these analyses are also qualified by several limita-
tions. First, it is possible that some women in our samples had one or
more pregnancy between the index child and the younger sibling
included in our analyses that ended in miscarriage, stillbirth, or child
death. Pregnancy histories were collected at follow-up for the RDNS
sample, and among those with a child included in this analysis, 4%
reported more than one pregnancy after the index child. Although
similar data are not available for DYAD-G, the rate is likely a bit higher
given that more time elapsed between the end of maternal supple-
mentation during the main trial and follow-up data collection. In these
cases, the pathway between the nutritional status of the mother dur-
ing the index pregnancy and postpartum period and the growth status
of her next living child is less direct. Another limitation is that having
another child after the index child was a choice variable, resulting in a
selected (and relatively small) sample of siblings at follow-up. In the
RDNS sample, there was a significant by-group difference in the likeli-
hood of having a younger sibling who was measured at follow-up
(no difference in the DYAD-G sample), and in both samples, there
were differences in the background characteristics of those with and
without a younger sibling measured at follow-up. Some of these dif-
ferences, which included maternal age, maternal parity, maternal BMI,
and house asset index score in the RDNS sample and maternal parity,
maternal age, and maternal height in the DYAD-G sample, were
expected (i.e., we would expect older mothers and multiparous
mothers to be less likely to have another child). The other differences
were generally small in magnitude, and these differences, along with
other background characteristics, were well balanced among interven-
tion groups in the follow-up samples. There were also differences in
the characteristics of the follow-up and lost to follow-up samples,
though the magnitude of the differences were small. These
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differences may have implications with regard to the generalizability
of the findings. However, because the follow-up sample of younger
siblings was balanced (i.e., no differences in background characteris-
tics between intervention groups), we consider the results to be inter-
nally valid. Finally, it is possible that improved maternal nutrition
during a previous pregnancy and postpartum period might have
improved a mother's nutritional status during a subsequent preg-
nancy, resulting in improved birth outcomes for the subsequent child.
Because we do not have any information on maternal nutrition during
her pregnancy with the younger sibling, nor on younger siblings' birth
outcomes, we were unable to assess this possibility.
For the past decade, the global nutrition community has been
focused on assessing and implementing nutrition interventions during
the first 1,000 days in an effort to prevent the detrimental short- and
long-term impacts of undernutrition during this critical window.
Increasingly, however, attention is broadening beyond the first
1,000 days to include the preconception period and the potential for
interventions that improve preconception maternal nutrition to trans-
late into improved child outcomes beyond what is achievable with
interventions that start after conception. This study was unique in
that it evaluated the potential for a nutrition intervention during the
previous pregnancy and postpartum period to impact the growth sta-
tus of a subsequent child, and it is important to specify what we can
and cannot conclude from the results of this evaluation. What we can
conclude is that, overall in these specific settings and without addi-
tional intervention, the benefits of maternal supplementation with
LNS or MMN during pregnancy and the first 6 months postpartum did
not extend to the next child in terms of improved growth status
beyond any effects of IFA alone. We cannot, however, conclude from
these results that improved maternal preconception nutrition does
not improve child growth. More research is needed to understand
how preconception nutrition interventions can be most effectively
designed and targeted. In our studies, women in the control groups
received IFA, so we were not able to assess the impact of IFA
received preconceptionally on the growth status of the subsequent
child. Given the global prevalence of iron-deficiency anaemia among
women of reproductive age, the research agenda should include stud-
ies designed to test whether the provision of IFA alone to women of
reproductive age, and especially to young women preconceptionally,
improves birth and child growth outcomes.
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